Acella Pharmaceuticals, LLC recalls
4 recalls on record · FDA
Every recall we have on record for Acella Pharmaceuticals, LLC, compiled from federal safety data. Check the hazard, the remedy, and how serious each one is, and always confirm on the official notice.
Filter:
Health Serious
NAPROXEN ORAL SUSPENSION, USP, 125 mg/5mL, Rx only, 16fl oz (473 mL) bottles, Distributed…
Chemical contamination; presence of lead and lithium above specification
Acella Pharmaceuticals, LLC May 13, 2026
Read the recall
Health Serious
Doxycycline Hyclate Tablets, USP 100 mg*, 500-count bottle, Rx Only, Distributed by:…
Failed dissolution specifications: Stability testing found that the lot did not meet dissolution specifications.
Acella Pharmaceuticals, LLC Oct 15, 2025
Read the recall
Health Moderate
Sodium Sulfacetamide 10% Sulfur 4% Cleansing Pads, Net weight 3.7g (60 cleansing pads Net…
Subpotent drug: Out of specification for assay at the end-of-shelf-life 24-month period.
Acella Pharmaceuticals, LLC Dec 7, 2022
Read the recall
Health Moderate
Phenytoin Sodium Injection, USP, 250 mg/5 mL, NDC 42192-614-05, packaged in 10 x 5 mL…
Labeling: Not elsewhere classified; the product is being recalled because of customer complaints that the primary vial label was missing a barcode.
Acella Pharmaceuticals, LLC Nov 30, 2022
Read the recall